Integra Lifesciences Holdings (IART) Current Assets (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Current Assets data on file, last reported at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 5.85% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 5.85% YoY), and the FY2025 full-year result was $1.2 billion, up 7.2% from the prior year.
• Current Assets grew to $1.2 billion in Q1 2026, from $1.2 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.4 billion in Q1 2024 to a low of $1.0 billion in Q3 2023.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 37.51% in 2024 and dropped 21.79% in 2025, its largest moves.
• Tracing IART's Current Assets over 5 years: stood at $1.2 billion in 2022, then fell by 8.91% to $1.1 billion in 2023, then rose by 2.23% to $1.1 billion in 2024, then grew by 7.2% to $1.2 billion in 2025, then advanced by 1.08% to $1.2 billion in 2026.
• Business Quant data shows IART's Current Assets at $1.2 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.